Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Facephi BiometriaXMAD:FACE +1.14%70 Debt-to-EBITDA is 0.37 as of Dec. 2025, which is 75% below its 10-year median of 1.47. GuruFocus rates XMAD:FACE with a GF Score™ of 70/100 and a GF Value™ of €2.95 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 1,716 Software companies, Facephi Biometria ranks better than 53.73% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Facephi Biometria's Debt-to-EBITDA or its related term are showing as below:
XMAD:FACE'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -46.25 Med: 1.47 Max: 7.58
Current: 0.91
During the past 13 years, the highest Debt-to-EBITDA Ratio of Facephi Biometria was 7.58. The lowest was -46.25. And the median was 1.47.
XMAD:FACE's Debt-to-EBITDA is ranked better than 53.73% of 1716
companies
in the Software industry
Industry Median: 1.08
vs XMAD:FACE: 0.91
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Facephi Biometria Debt-to-EBITDA Related Terms
Facephi Biometria Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Facephi Biometria's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XMAD:FACE vs UBER, SHOP, CRM: Debt-to-EBITDA Comparison
For the Software - Application subindustry, Facephi Biometria's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Facephi Biometria Debt-to-EBITDA vs Software Industry
For the Software industry and Technology sector, Facephi Biometria's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Facephi Biometria's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is two times the quarterly (Dec. 2025) EBITDA data.
Facephi Biometria (XMAD:FACE) has a Debt-to-EBITDA of 0.37 as of Dec. 2025. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Facephi Biometria. This is 75% below median its historical median of 1.47. According to the industry distribution chart, Facephi Biometria ranks #794 out of 1716 companies in the Software industry, placing it in the top 46.3%.
Is Facephi Biometria's Debt-to-EBITDA too high?
Facephi Biometria's current Debt-to-EBITDA of 0.37 is 75% below median its 10-year median of 1.47. The Software industry median Debt-to-EBITDA is 1.08. Facephi Biometria's value of 0.37 is 65.7% below this industry median. Based on the distribution chart, Facephi Biometria ranks #794 out of 1716 companies in the Software industry, which is above the industry midpoint. Overall, Facephi Biometria has a GF Score™ of 70/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Facephi Biometria's Debt-to-EBITDA compare to UBER and SHOP?
According to the Software industry distribution chart, Facephi Biometria ranks #794 out of 1716 companies for Debt-to-EBITDA. This puts Facephi Biometria in the upper half of its industry. The industry median Debt-to-EBITDA is 1.08. Facephi Biometria's value of 0.37 is 65.7% below this benchmark. While the company's 10-year median is 1.47 vs. the industry median of 1.08, Facephi Biometria has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Software company?
The median Debt-to-EBITDA among Software companies is 1.08, based on 1,716 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Facephi Biometria's current Debt-to-EBITDA of 0.37 is 65.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Facephi Biometria. For the Software industry, the median Debt-to-EBITDA is 1.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Facephi Biometria's current Debt-to-EBITDA is 0.37, which is 75% below median its own 10-year median of 1.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Facephi Biometria stock overvalued right now?
Based on GuruFocus' analysis, Facephi Biometria (XMAD:FACE) is currently considered Possible Value Trap. The stock's GF Value™ is €2.95, compared to a current price of €1.77 — trading 40% below its estimated fair value. The current Debt-to-EBITDA is 0.37, which is 75% below median its 10-year median of 1.47 and 65.7% below the Software industry median of 1.08. Facephi Biometria's overall GF Score™ is 70/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Facephi Biometria (XMAD:FACE), the current Debt-to-EBITDA is 0.37 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Facephi Biometria (XMAD:FACE) Overvalued in 2026?
Based on GuruFocus' analysis, Facephi Biometria stock appears to be undervalued.
The current stock price of €1.77 is trading 40% below its estimated GF Value™ of €2.95.
GuruFocus considers Facephi Biometria to be Possible Value Trap.
Key valuation signals for XMAD:FACE:
Debt-to-EBITDA: 0.37 (75% below median its 10-year median of 1.47)
GF Value™: €2.95 vs. price of €1.77 (40% below fair value)
Industry Position: 65.7% below the Software median (#794 of 1716)
No single metric tells the full story. See the XMAD:FACE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Facephi Biometria SA is a technology company specializing in digital identity verification, fraud prevention, and regulatory compliance solutions. It delivers an AI/ML-powered Identity & Anti-Fraud platform that provides a comprehensive 360-degree end-to-end approach to digital protection. It develops solutions that make digital processes safer, more accessible, and fraud-free. Its technologies help prevent identity theft while ensuring the ethical management and protection of personal data. Geographically, it operates in Spain and the rest of Countries with the majority of the revenue from the rest of Countries.
70GF Score
Get the complete analysis for XMAD:FACE
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XMAD:FACE has been successfully added to your 
